Pacific Biosciences of California Statistics
NASDAQ: PACBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
1.63-0.13 (-7.39%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pacific Biosciences of California by the numbers
Pacific Biosciences of California has a market capitalization of $508.9 million based on 312.24M shares outstanding. With trailing EPS of $-0.42, Pacific Biosciences of California is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.6% below its 50-day average and 2.2% above its 200-day average.
Average daily trading volume is 13.23M shares, or about $21.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PACB valuation vs. peer median
| Metric | PACB | Peer median | Difference |
|---|---|---|---|
| Market cap | $508.95M | $84.48M | +502% |
| Avg. volume | 13.23M | 649.32K | +1937% |
Peer median across 8 companies: NAUT, LAB, CTKB, QTRX, SEER, HBIO, RPID, PRPO.
Valuation
- Market cap
- $508.95M
- Price / sales (latest FY)
- 3.18
- EPS (TTM)
- $-0.42
- Shares outstanding
- 312.24M
Price and trading
- Previous close
- 1.76
- Open
- 1.69
- Day range
- 1.61 – 1.73
- 52-week range
- 1.07 – 3.44
- 52-week change
- -26.58%
- Beta
- —
- Volume
- 13.68M
- Average volume
- 13.23M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 508.95M
- Forward Pe
- -4.06
- Eps
- -0.42
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.44
- Week52 Low
- 1.07
- Avg Volume
- 13.23M
- Shares Outstanding
- 312.24M
- Ma50
- 2.05
- Ma200
- 1.60
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -52.62%
- Pct From52w Low
- 52.34%